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Abstract: Amide bond formation is one of the most important
reactions in pharmaceutical synthetic chemistry. The develop-
ment of sustainable methods for amide bond formation,
including those that are catalyzed by enzymes, is therefore of
significant interest. The ATP-dependent amide bond synthe-
tase (ABS) enzyme McbA, from Marinactinospora thermoto-
lerans, catalyzes the formation of amides as part of the
biosynthetic pathway towards the marinacarboline secondary
metabolites. The reaction proceeds via an adenylate intermedi-
ate, with both adenylation and amidation steps catalyzed
within one active site. In this study, McbA was applied to the
synthesis of pharmaceutical-type amides from a range of aryl
carboxylic acids with partner amines provided at 1–5 molar
equivalents. The structure of McbA revealed the structural
determinants of aryl acid substrate tolerance and differences in
conformation associated with the two half reactions catalyzed.
The catalytic performance of McbA, coupled with the struc-
ture, suggest that this and other ABS enzymes may be
engineered for applications in the sustainable synthesis of
pharmaceutically relevant (chiral) amides.
The formation of amide bonds is one of the most important
reactions in pharmaceutical synthetic chemistry, accounting
for up to 16 % of all synthetic steps in medicinal chemistry
laboratories.[1] Amide bond synthesis typically involves acti-
vation of a carboxylic acid, using either toxic chlorinating
agents, or atom-inefficient coupling reagents,[2] and so there is
an urgent need to investigate methods for amide bond
formation that are sustainable in terms of reagent safety
and atom efficiency. Enzymatic methods for amide bond
synthesis that display these advantages are thus appealing.[3,4]
Amide bonds are encountered in secondary metabolites that
are synthesized by non-ribosomal peptide synthases
(NRPSs).[5] In this case, the formation of the amide is
complex, requiring ATP-dependent formation of an inter-
mediate adenylate of the carboxylic acid substrate, followed
by transfer to a phosphopantetheine thiol enabled by an acyl/
peptidyl carrier protein (ACP or PCP), followed by con-
densation with the amine substrate, with each process taking
place in a separate domain of a large, multidomain NRPS
enzyme. While NRPS-mediated amide bond formation may
have a role in synthetic biology pathways towards amides,[6]
their structural and catalytic complexity militates against their
application in preparative in vitro biocatalysis. Hydrolases,
such as N-acylases[7] and lipases,[8] have been employed for
amide bond formation and are attractive in terms of their
simplicity and efficiency, but they often require ester sub-
strates and suffer from poor substrate scope. More recently,
Flitsch and co-workers have recruited the adenylate-forming
ability of a carboxylate reductase (CAR) adenylation-
domain-plus-peptidyl carrier protein (CAR-A-PCP) to the
formation of amides, although a 100-fold excess of amine was
required to drive reactions to high conversions.[9]
ATP-dependent amide bond synthetases (ABSs) have
been discovered in secondary metabolite pathways leading to
compounds such as novobiocin,[10] cloromycin,[11] and cou-
mermycin.[12] The enzymes NovL and CouL, for example,
couple the aminoflavone 1 with carboxylic acids 2 and 4 in
their respective biosynthetic pathways to give amide products
3 and 5 (Scheme 1A).
These enzymes are apparently capable of catalyzing
formation of the adenylate, but also of binding the amine
for the coupling reaction within the same active site, with no
involvement of separate acyl carrier protein or condensation
domains. A further enzyme, McbA, has recently been
reported in the biosynthetic pathway towards the marinacar-
bolines in Marinactinospora thermotolerans by Ji and co-
workers.[13, 14] McbA catalyzes the ATP-dependent coupling of
the b-carboline derivative 6 with 2-phenylethylamine a to
form 6a via adenylate 7 (Scheme 1B), but, unlike other ABSs,
McbA also accepted other amines, including substituted 2-
phenylethylamines and tryptamines, thus indicating some
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promise for the application of this enzyme to reactions with
a wider substrate spectrum.[14] These studies prompted us to
further examine the activity of McbA to include a range of b-
carboline and other aryl carboxylic acid acceptors. We also
determined the structure of McbA in complex with AMP and
6, which revealed the substrate binding interactions within the
active site, and may serve as a platform for protein engineer-
ing to expand the substrate specificity of this and related ABS
enzymes.
McbA was expressed from a synthetic gene and the
protein purified using IMAC followed by gel filtration
(Figures S1, S2 in the Supporting Information). A sample of
the pure enzyme (1 mgmL@1; 9.4 nmol) was applied to the
coupling of 0.4 mm acid 6 and 0.6 mm 2-phenylethylamine a,
in the presence of 2 mm ATP on an analytical scale, and full
conversion to product amide 6a was observed within 1 h using
HPLC. The standard amide product was prepared by reacting
the b-carboline ester with the amine in DMSO at 90 8C (see
the Supporting Information). We then further explored the
constraints on substrate structure in the McbA-catalyzed
reaction, but, in contrast to previous work,[14] we focused on
the structure of the carboxylic acid acceptor (Scheme 2).
Carboxylic acid substrates 6 and 8–11 were synthesized
using Pictet–Spengler condensations of tryptophan-derived
esters with relevant aldehydes, followed by hydrolysis of the
ester products, as detailed in the Supporting Information.
Substitution of the acyl group in position 1 of the pyridine ring
with a secondary hydroxymethyl (8) reduced the conversion
to 21 % of product 8 a after 1 h, but 96% conversion was
achieved after 24 h. An increase in the size of the substituent
to benzoyl 9 gave conversions to product 9 a of 8% and 82%
after 1 h and 24 h, respectively. Replacement by an ethyl
group 10 showed that an oxygen atom on this substituent was
not necessary, with 100 % conversion to product 10 a again
achieved after 24 h. Even replacement with H (11) resulted in
6% conversion to 11a after 24 h. The activity of the enzyme
was then tested using carboxylic acids 6 and 8–11 with amines
a–d (Scheme 2, Table 1).
McbA catalyzed the formation of 6a and 6 b with 100%
and 81% conversion, respectively, thus confirming the find-
ings of Ji and co-workers.[14] However, McbA also catalyzed
the coupling of 6 to the racemic chiral amines c and d to form
6c and 6d, although with lower conversions of 6% and 26 %.
Interestingly, analysis of the product 6d by chiral HPLC
revealed it to be predominantly of (S)-configuration, and with
an ee of 96 % (Figure S3), thus indicating that McbA is
capable of performing kinetic resolution reactions. Trypt-
amine (b) was also coupled to 10 to give 10 b in 91 % yield. 1-
Phenylethylamine (c) proved to be a poor donor overall, but
3-phenyl-1-methylpropylamine d was coupled with 8 to form
amide 8d with a conversion of 17 %. Some of the b-carboline
amides synthesized here have been shown to have biological
activity, most notably against benzodiazepine receptors,
which was first reported in the 1980s,[15] and are of interest
as treatments for alcohol abuse, for example.[16]
In order to investigate the broader applicability of McbA
to amide bond synthesis, aryl acid substrates 12–19, which
have structures more diverged from the b-carboline acid
Scheme 1. A) Amide bond synthesis by ATP-dependent amide bond
synthetases (ABSs) NovL and CouL involved in secondary metabolism
in actinomycetes. B) Formation of marinacarbolines such as 6a from
b-carboline acid 6 and amine a catalyzed by McbA from Marinactino-
spora thermotolerans.
Scheme 2. b-carboline carboxylic acid and amine partners for McbA-
catalyzed amide bond formations.
Table 1: ATP-dependent amide couplings by McbA.[a]
Amine
Acid a b c d
6 100 81 6 26
8 96 100 0 17
9 82 0 0 0
10 100 91 0 0
11 6 0 0 0
[a] Values represent % conversions to amide products after 24 h as
determined by HPLC analysis.
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platform, were then tested with 2-phenylethylamine (a) in an
effort to produce amide products 12 a to 19a (Table 2).
Overall, McbA displayed a surprisingly broad substrate
range, including substrates such as naphthoic acid 14, indole
carboxylic acids 15 and 16, and benzofuran-5-carboxylic acid
17, although quinoline substrate 18 was transformed with low
conversion. Strikingly, McbA was also able to couple benzoic
acid 19 with a with a modest but significant conversion of
24%.
To investigate the promiscuity in term of aryl acid
recognition by McbA, the structure of the enzyme was
determined using X-ray crystallography. A K483A mutant co-
crystallised with AMP, magnesium ions, and the b-carboline
acid substrate 6 yielded crystals of diffraction quality. The
structure was solved using molecular replacement, and
refined to a resolution of 2.80 c (data collection and refine-
ment statistics can be found in Table S2 in the Supporting
Information). McbA adopts a structure within the ANL
superfamily of adenylating enzymes defined by Gulick,[17] and
which includes firefly luciferase,[18] acetyl-CoA synthase,[19]
and standalone adenylation domains of NRPSs, including the
dihydroxybenzoate adenylating enzyme enzyme DhbE[20]
from the bacillibactin biosynthetic pathway. Each ANL
enzyme is characterized by a two-domain structure in which
a large N-terminal domain is coupled to a smaller C-terminal
one, consisting of 4–500 and 100 amino acid residues,
respectively. Crucially, the structures of many ANL enzymes
have revealed substantial relative domain rotation during the
reaction coordinate, with one conformation (“adenylation”)
assumed for adenylate formation from the carboxylate
substrate and ATP, and a second, (“thiolation”) in which
the C-terminal domain rotates to enable the ligation reaction
between the phosphopantetheinate thiol and the adenylate
intermediate.
The McbA structure features the two predicted domains:
the large N-terminal domain of residues 1–394 (McbAN) and
the smaller C-terminal one comprising residues 395–494
(McbAC), with the hinge residue at Q394. The McbA
structure is unusual however, in that, of five molecules
within the asymmetric unit, four (A–D) are in the “adenyla-
tion” conformation (Figure 1a) and one (E) is in the
“thiolation” state described above, which we have termed
“amidation” (Figure 1b) for McbA. The adenylation confor-
mer of McbA superimposes well with other ANL enzymes
crystallized in the same state, including PheA (PDB I-
D: 1AMU, 2.1 c over 431 Ca atoms),[21] DhbE
(PDB ID: 1MD9, 2.3 c over 445),[20] and the recently deter-
mined structure of the relevant “A” domain from CAR from
Nocardia iowenis (NiCAR) in complex with benzoic acid and
AMP (PDB ID: 5MSD, 2.8 c over 406).[22]
The substrate 6 is bound within a hydrophobic pocket
stacked between the loop between G295 and F301 on one face
and L202 on the other (Figure 2). Few specific interactions
between active-site residues and the substrate are made,
except that the carbonyl oxygen and pyridine nitrogen of 6
interact with the backbone N-H and C=O of G295 at
distances of approximately 3.9 and 3.4 c respectively. The
relative lack of specific interactions may help to explain the
relaxed specificity of McbA for the range of aryl acids used in
this study. The exception was quinoline derivative 18, in which
the N-atom in the 1-position has had an adverse effect on
conversion, perhaps disrupting the hydrophobic interaction
made by the native ligand with F301. Residue D201, which
points away from 6 in the active site, is replaced in CARs and
DhbE by H300, and is close to the benzoic acid carboxylate in
the CAR–AMP complex 5MSD. This histidine has been
implicated in the catalysis of both adenylation and thiolation
Table 2: ATP-dependent coupling of 12–19 with amine a by McbA.[a]
Acid Product Conversion [%]
12 12 a 34
13 13 a 23
14 14 a 43
15 15 a 40
16 16 a 41
17 17 a 39
18 18 a 4
19 19 a 24
[a] Values represent % conversions to amide products after 24 h as
determined by HPLC analysis.
Figure 1. Structures of McbA in the adenylation (a) and amidation (b) conformations. In each case the protein is colored in green from residues
1–394 (McbAN) and coral from 395–494 (McbAC). AMP (yellow) is bound at the domain interface and 6 (blue) within a binding pocket in the N-
terminal domain. The McbAC domain in (b) is rotated 1498 relative to the larger McbAN domain compared with their orientations in (a).
Angewandte
ChemieCommunications
11586 www.angewandte.org T 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2018, 57, 11584 –11588
reactions in 4-chlorobenzoyl-CoA ligase (PDB IDs: 4CBL,
3CW8, 3CW9).[23, 24]
The amidation conformer of McbA superimposes well
with the thiolation conformer of 4-CBL (PDB ID: 3CW9,
2.0 c over 430 Ca atoms) and also the “A” domain in the
structure of CAR-A-PCP (PDB ID: 5MSS, 2.5 c over 402),
the construct used in amide bond forming reactions described
previously.[9] The structure of 4-CBL in the thiolation state, in
complex with 4-chlorophenacyl- CoA (4-CPA-CoA,
PDB ID: 3CW9; Figure S3a)[23] identifies the binding site
for the thiolation product, and permits a comparison with the
equivalent region of McbA (Figure S3b) The surfaces of the
enzymes show that positively charged residues in 4-CBL, such
as R87, which interact with the phosphates in 4-CPA-CoA,
are absent in McbA; indeed the entrance to the active site
features three residues with carboxylate side chains (D463,
E221 and E400), which may favor interaction with incoming
amine substrates.
The McbA-catalyzed synthesis of selected amides was
scaled up to utilize 50 mg (0.20 mmol) of aryl acids 6, 10, 14,
16, 17, and 19 in a 50 mL reaction volume, with 1–5 molar
equivalents 2-phenylethylamine (a) and two equivalents of
ATP (198 mg; 0.40 mmol). Amide products 6a, 10a, 14a, 17a,
and 19a were isolated by simple liquid-liquid extraction into
ethyl acetate, giving isolated yields of between 50% and 85%
of the amide products without further purification (Table 3).
16a was also isolated, although only in 15% yield owing to
complications in extraction of this indole product. These
results compare favorably with the application of CAR-A-
PCP to preparative amide bond formation,[9] since 100 equiv-
alents of amine donor were required for those reactions,
compared to the low ratios reported here. The difference may
reflect of the active participation of McbA in amine binding
and catalysis of amidation, which was not yet established for
the CAR-A-PCP reaction. The results offer promise for the
application of McbA-type enzymes in preparative biocat-
alyzed reactions, particularly if ATP recycling methods,
currently a subject of significant interest in biocatalysis,[25]
were to be employed.
The efficient biocatalytic formation of amide bonds for
the preparation of pharmaceutical-type amides is one of the
most significant reactions for which biocatalytic alternatives
are being sought. The studies presented here suggest that
McbA and related ABS enzymes may provide starting points
for the evolution of activity towards a wider range of
carboxylic acid and amine partners, using the structure of
McbA as a basis for structure-guided evolution.
Experimental Section
Details of target selection, gene cloning and expression, enzyme
purification and assay, synthesis of substrates and product standards,
HPLC analyses, biotransformation protocols, crystallisation and data
collection and refinement can be found in the Supporting Informa-
tion.
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